Samaritan Licenses Exclusive Rights to Infectious Disease Compounds From Georgetown University Infectious Diseases Apr 10, 2008
Shire Human Genetic Therapies AB Signs Exclusive Marketing and Distribution Deal with Samaritan to Launch REPLAGAL® for Fabry Disease in Greece and Cyprus Pharmaceuticals Apr 10, 2008
